Literature DB >> 15451051

The role of heme oxygenase-1 promoter polymorphisms in human disease.

Markus Exner1, Erich Minar, Oswald Wagner, Martin Schillinger.   

Abstract

Heme oxygenase (HO) seems to be a novel protective factor with potent anti-inflammatory, anti-oxidant, and anti-proliferative effects. HO-1, the inducible isoform, is expressed in various tissues and is upregulated by multiple stimuli. However, humans differ quantitatively in their ability to mount an HO-1 response, modulated by two potentially functional polymorphisms in the HO-1 gene promoter region. From several studies it seems that the ability of a patient with certain genotypes to respond strongly in terms of upregulating HO-1 may be an important endogenous protective factor. In the present article we systematically review the hitherto published evidence that promoter polymorphisms in the HO-1 gene exert functional importance by influencing the level of HO-1 expression in different organ systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451051     DOI: 10.1016/j.freeradbiomed.2004.07.008

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  129 in total

1.  Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.

Authors:  Trevor D Burt; Lillian Seu; Jeffrey E Mold; Attallah Kappas; Joseph M McCune
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics.

Authors:  S J Gibbons; P-J Verhulst; A Bharucha; G Farrugia
Journal:  Aliment Pharmacol Ther       Date:  2013-08-28       Impact factor: 8.171

3.  Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Authors:  Aki Murakami; Yoshihiro Fujimori; Yoshie Yoshikawa; Shusai Yamada; Kunihiro Tamura; Noriko Hirayama; Takayuki Terada; Kozo Kuribayashi; Chiharu Tabata; Kazuya Fukuoka; Tomoko Tamaoki; Takashi Nakano
Journal:  Lung       Date:  2012-01-21       Impact factor: 2.584

4.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

5.  Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation.

Authors:  Angelo A Chora; Paulo Fontoura; Andreia Cunha; Teresa F Pais; Sílvia Cardoso; Peggy P Ho; Lowen Y Lee; Raymond A Sobel; Lawrence Steinman; Miguel P Soares
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

6.  Haem oxygenase: a model for therapeutic intervention.

Authors:  Gregory J Quinlan; Anna L Lagan; Timothy W Evans
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

7.  HO-1 extends to stem cells.

Authors:  Richard J Cornall
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

8.  Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.

Authors:  Wei-Hong Hou; Lisa Rossi; Ying Shan; Jian-Yu Zheng; Richard-W Lambrecht; Herbert-L Bonkovsky
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

9.  First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans.

Authors:  A E Bharucha; A Kulkarni; K M Choi; M Camilleri; M Lempke; G J Brunn; S J Gibbons; A R Zinsmeister; G Farrugia
Journal:  Clin Pharmacol Ther       Date:  2009-12-02       Impact factor: 6.875

10.  Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosis.

Authors:  Michal J Tracz; Julio P Juncos; Joseph P Grande; Anthony J Croatt; Allan W Ackerman; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.